Protopanaxatriol-type ginsenosides differentially modulate type 1 and type 2 cytokines production from murine splenocytes
- PMID: 15770538
- DOI: 10.1055/s-2005-837817
Protopanaxatriol-type ginsenosides differentially modulate type 1 and type 2 cytokines production from murine splenocytes
Abstract
Seven protopanaxatriol-type ginsenosides and their aglycones including PPT, PT, -Re, -Rg (1), -F (1), -Rh (1), 20(R)-Rh (1) which are closely related in structure were studied for their effects on type 1 and type 2 cytokines production from murine splenocytes and their related mechanisms were examined. The results indicate that PPT, PT and ginsenoside-Re show hardly any or weak effects on concanavalin A (Con A)-induced production of IFN-gamma and IL-4. Ginsenoside-Rh (1) and 20(R)-Rh (1) induce a Con A-induced type 1 cytokine pattern by increasing the production of interleukin-12 (IL-12), the expression of IFN-gamma, T-bet and enhancing NF-kappaB DNA binding activity. In contrast ginsenosides-Rg (1) and -F (1) cause a Con A-induced type 2 cytokines response by increasing the expression of IL-4, GATA-3 and enhancing NF-kappaB DNA binding activity. Thus, these protopanaxatriol-type ginsenosides have different immunomodulatory effects, which might explain the complex immunomodulatory effect of Panax ginseng.
Similar articles
-
Immunoenhancing activity of protopanaxatriol-type ginsenoside-F3 in murine spleen cells.Acta Pharmacol Sin. 2004 Dec;25(12):1671-6. Acta Pharmacol Sin. 2004. PMID: 15569414
-
Ginsenoside-Ro enhances cell proliferation and modulates Th1/Th2 cytokines production in murine splenocytes.Yao Xue Xue Bao. 2005 Apr;40(4):332-6. Yao Xue Xue Bao. 2005. PMID: 16011261
-
Ginsenosides inhibit EGF-induced proliferation of renal proximal tubule cells via decrease of c-fos and c-jun gene expression in vitro.Planta Med. 2002 Nov;68(11):971-4. doi: 10.1055/s-2002-35659. Planta Med. 2002. PMID: 12451485
-
Therapeutic potential of Panax ginseng and ginsenosides in the treatment of chronic obstructive pulmonary disease.Complement Ther Med. 2014 Oct;22(5):944-53. doi: 10.1016/j.ctim.2014.08.006. Epub 2014 Aug 20. Complement Ther Med. 2014. PMID: 25440386 Review.
-
Biopharmaceutical characters and bioavailability improving strategies of ginsenosides.Fitoterapia. 2018 Sep;129:272-282. doi: 10.1016/j.fitote.2018.06.001. Epub 2018 Jun 5. Fitoterapia. 2018. PMID: 29883635 Review.
Cited by
-
Potential Immunoregulatory Mechanism of Plant Saponins: A Review.Molecules. 2023 Dec 23;29(1):113. doi: 10.3390/molecules29010113. Molecules. 2023. PMID: 38202696 Free PMC article. Review.
-
Ginseng extract and ginsenoside Rb1 attenuate carbon tetrachloride-induced liver fibrosis in rats.BMC Complement Altern Med. 2014 Oct 25;14:415. doi: 10.1186/1472-6882-14-415. BMC Complement Altern Med. 2014. PMID: 25344394 Free PMC article.
-
Chemical and bioactive comparison of flowers of Panax ginseng Meyer, Panax quinquefolius L., and Panax notoginseng Burk.J Ginseng Res. 2017 Oct;41(4):487-495. doi: 10.1016/j.jgr.2016.08.008. Epub 2016 Aug 26. J Ginseng Res. 2017. PMID: 29021695 Free PMC article.
-
Effects of Astragalus membranaceus in promoting T-helper cell type 1 polarization and interferon-gamma production by up-regulating T-bet expression in patients with asthma.Chin J Integr Med. 2006 Dec;12(4):262-7. doi: 10.1007/s11655-006-0262-y. Chin J Integr Med. 2006. PMID: 17361521
-
Exploring the therapeutic potential of triterpenoid saponins from Gymnema sylvestre: Mechanistic insights into hepatoprotection, immunomodulation, anticancer activities, molecular docking, and pharmacokinetics.Heliyon. 2024 Nov 30;10(23):e40850. doi: 10.1016/j.heliyon.2024.e40850. eCollection 2024 Dec 15. Heliyon. 2024. PMID: 39719988 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical